EUVIMEDEUVIMED entdecken
Open Access

Visualizing the target estimand in comparative effectiveness studies with multiple treatments

Gabrielle Simoneau iD, Marian Mitroiu iD, Thomas Pa Debray iD, Wei Wei, Stan Rw Wijn iD, Joana Caldas Magalhães, Justin Bohn, Changyu Shen iD, Fabio Pellegrini iD, Carl de Moor iD

Journal of Comparative Effectiveness Research · 2024

DOI: 10.57264/cer-2023-0089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2024. Verfasst von Gabrielle Simoneau und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biogen Canada, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Crotonates, Hydroxybutyrates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Comparative effectiveness research using real-world data often involves pairwise propensity score matching to adjust for confounding bias. We show that corresponding treatment effect estimates may have limited external validity, and propose two visualization tools to clarify the target estimand. Materials & methods: We conduct a simulation study to demonstrate, with bivariate ellipses and joy plots, that differences in covariate distributions across treatment groups may affect the external validity of treatment effect estimates. We showcase how these visualization tools can facilitate the interpretation of target estimands in a case study comparing the effectiveness of teriflunomide (TERI), dimethyl fumarate (DMF) and natalizumab (NAT) on manual dexterity in patients with multiple sclerosis.

Results

In the simulation study, estimates of the treatment effect greatly differed depending on the target population. For example, when comparing treatment B with C, the estimated treatment effect (and respective standard error) varied from -0.27 (0.03) to -0.37 (0.04) in the type of patients initially receiving treatment B and C, respectively. Visualization of the matched samples revealed that covariate distributions vary for each comparison and cannot be used to target one common treatment effect for the three treatment comparisons. In the case study, the bivariate distribution of age and disease duration varied across the population of patients receiving TERI, DMF or NAT. Although results suggest that DMF and NAT improve manual dexterity at 1 year compared with TERI, the effectiveness of DMF versus NAT differs depending on which target estimand is used.

Conclusion

Visualization tools may help to clarify the target population in comparative effectiveness studies and resolve ambiguity about the interpretation of estimated treatment effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple Sclerosis, Relapsing-RemittingMultiple SclerosisCrotonatesHydroxybutyratesNitrilesToluidinesHumansImmunosuppressive AgentsFingolimod HydrochlorideDimethyl Fumarate

Stichwörter der Autor:innen

comparative effectivenessmatchingmultiple sclerosispropensity scorevisualization

Substanzen

Immunosuppressive AgentsFingolimod HydrochlorideDimethyl FumarateteriflunomideCrotonatesHydroxybutyratesNitrilesToluidines

Autor:innen und Institutionen

  • Biogen Canada, Toronto, ON, Canada.
  • Biogen International GmbH, Baar, Zug, 6340, Switzerland.
  • Julius Centre for Health Sciences & Primary Care, University Medical Centre, University of Utrecht, Utrecht, 3584CG, The Netherlands.
  • Smart Data Analysis & Statistics, Utrecht, 3524HM, The Netherlands.
  • Medip Analytics, Nijmegen, 6534AT, The Netherlands.
  • Johnson & Johnson, New Brunswick, NJ, USA.

ORCID-Profile: Gabrielle Simoneau, Marian Mitroiu, Thomas Pa Debray, Stan Rw Wijn, Changyu Shen, Fabio Pellegrini, Carl de Moor

Zitieren

APA

Simoneau, G., Mitroiu, M., Debray, T. P., Wei, W., Wijn, S. R., Magalhães, J. C., Bohn, J., Shen, C., Pellegrini, F., & Moor, C. (2024). Visualizing the target estimand in comparative effectiveness studies with multiple treatments. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2023-0089

Vancouver

Simoneau G, Mitroiu M, Debray TP, Wei W, Wijn SR, Magalhães JC, et al. Visualizing the target estimand in comparative effectiveness studies with multiple treatments. Journal of Comparative Effectiveness Research. 2024. doi:10.57264/cer-2023-0089

BibTeX
@article{Simoneau2024,
  author = {Simoneau, Gabrielle and Mitroiu, Marian and Debray, Thomas Pa and Wei, Wei and Wijn, Stan Rw and Magalhães, Joana Caldas and Bohn, Justin and Shen, Changyu and Pellegrini, Fabio and Moor, Carl de},
  title = {Visualizing the target estimand in comparative effectiveness studies with multiple treatments},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2024},
  doi = {10.57264/cer-2023-0089}
}
Kostenlos starten →